Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
China
· Delayed Price · Currency is CNY 27.78
-0.66 (-2.32%)
Jun 4, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Chemical | 717.61M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemical Growth | 92.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics | 670.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Growth | -12.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Manufacture Organization/Contract Development and Manufacturing Organization | 16.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Manufacture Organization/Contract Development and Manufacturing Organization Growth | 45.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Promotional Services | 4.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Promotional Services Growth | 47.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Technical Services | 1.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Technical Services Growth | 143.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Real Estate Leasing | 780.73K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Real Estate Leasing Growth | -81.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 708.89K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 226.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Recombinant Human Interferon a2b | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Recombinant Human Interferon a2b Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Compound Glycyrrhizin Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Compound Glycyrrhizin Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| China | 1.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 21.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 1.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 418.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|